George Clinical – CRO United States

George Clinical in The United States

Asia-Pacific’s leading contract research organisation (CRO), George Clinical, has recently registered as a new entity in North Carolina, USA.

Headquartered in Sydney, Australia, George Clinical has offices in China, India, Hong Kong, Taiwan, Malaysia, New Zealand, United Kingdom and Czech Republic.

Over the years, George Clinical has grown rapidly across the Asia-Pacific region and is continuing to develop global operations. The combination of a strong commercial proficiency and clinical research excellence will serve George Clinical fittingly; pursuing a global position as a high quality CRO with substantial clinical and scientific assets.

With this new entity in the United States, George Clinical is now closer to its customers, which are primarily US based. The physical presence will also facilitate operational activities in the United States in the near future.

What are the benefits of conducting clinical trials in the US?

  • The current situation in which clinical research is being sent abroad just to get trials completed is unsustainable.
  • Clinical trials in a number of other countries cost less than they currently do in the United States.
  • If a large outcome trial requires enrolling a large amount of patients, for example, selecting trial sites in Russia or India instead of the United States can result in hundreds of millions of dollars in savings.
  • The overall cost associated with gathering the necessary resources to conduct a clinical trial is lower in a number of countries than in the United States.
  • In these countries, the charges to clinical trial sponsors for conducting a clinical trial with physician involvement are lower than they would be in the United States.
  • Some also argue that clinical trials conducted outside of the United States are of higher quality because of better adherence to trial protocols and better patient follow-up.

What are the prevalent diseases in the US?

  1. Heart Disease
  2. Cancer
  3. Chronic Lower respiratory disease
  4. Stroke
  5. Alzheimer’s disease
  6. Diabetes
  7. Kidney Disease

George Clinical US News

No relief in sight for those suffering from sciatica

A drug increasingly being prescribed for treating sciatica has been revealed to be no better than placebo, in new research from The George Institute for Global Health.

Improving COPD management in women

With more women dying from chronic obstructive pulmonary disease (COPD) than breast and lung cancer combined, a new report co-authored by Professor Christine Jenkins from The George Institute for Global Health highlights the need for a new global approach to tackling the dis...

A Day for Women’s Health

By Professor Robyn Norton

Circulation profiles The George Institute’s Chief Scientist in special edition

The American Heart Association’s renowned journal Circulation has interviewed The George Institute for Global Health’s Chief Scientist, Professor Anushka Patel, in a special edition focusing on women and heart disease.

Tackling China's growing burden of injury and trauma

The George Institute for Global Health and China's National Center for Chronic and Non-Communicable Disease Control and Prevention (NCNCD) have signed a Memorandum of Understanding to address the growing burden of injury and trauma in China.

Less is more: potential breakthrough for treating hypertension with ultra low-dose combinations

A small but clinically important trial of a new ultra-low dose four-in-one pill to treat high blood pressure has produced remarkable results.
Tweet about this on TwitterShare on FacebookShare on LinkedIn


Number of Personnel: 2
In-country Services:Business Development
Population:321 million
Official Language:English 79.2%, Spanish 12.9%, other Indo-European 3.8%, Asian and Pacific island 3.3%, other 0.9%
Hospital Records Language:English

Twitter Facebook LinkedIn